AccurKardia
Valuation
$4.6M
2025 Revenue
$1.5M
Funding
$0
Team
14
Founded
2019
How AccurKardia grew AccurKardia to $1.5M revenue with a 14 person team in 2025.
AccurKardia is an ECG-led diagnostics software company transforming ECG signals into a broad biomarker and diagnostic tool for disease management in cardiology and beyond. Our mission is to improve patient outcomes and save lives on a global scale. Our flagship product, AccurECG™, is an FDA-cleared (Class II SaMD), cloud-based, device-agnostic software providing fully automated ECG interpretation, capable of detecting up to 13 arrhythmias. It assists cardiac monitoring companies in analyzing ECGs from holters, event recorders, and cardiac telemetry devices, significantly enhancing efficiency and patient care. Recently, AccurKardia reached a major milestone with the FDA Breakthrough Device Designation for our AI-driven ECG-based Aortic Valve Stenosis (AK-AVS) screening software. This achievement highlights our dedication to advancing early detection and precision medicine in cardiovascular care. We are also proud participants in the MedTech Innovator 2024 Cohort and the Heart & Brain Health Accelerator track, in collaboration with the American Heart Association’s Center for Health Technology and Innovation.
Last updated
AccurKardia Revenue
In 2025, AccurKardia's revenue reached $1.5M. Since its launch in 2019, AccurKardia has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2025 | AccurKardia Hit $1.5m revenue in September 2025 |
| 2019 | Launched with $0 revenue |
AccurKardia Valuation, Funding Rounds
AccurKardia's most recent disclosed valuation is $4.6M.
AccurKardia is a bootstrapped Generative AI Software startup. Founded in 2019, AccurKardia has grown to $1.5M in revenue without raising any venture capital or outside funding.
As a self-funded Generative AI Software SaaS company, AccurKardia has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold |
|---|
AccurKardia Employees & Team Size
AccurKardia employs approximately 14 people as of 2026.
AccurKardia has 14 total employees in different roles and functions.
| Year | Milestone |
|---|---|
| 2025 | Reached 14 employees (September 2025) |
Customers
We do not have customer count information for AccurKardia yet.
Frequently Asked Questions about AccurKardia
What is AccurKardia's revenue?
AccurKardia generates $1.5M in revenue.
How much funding does AccurKardia have?
AccurKardia raised $0.
How many employees does AccurKardia have?
AccurKardia has 14 employees.
Where is AccurKardia headquarters?
AccurKardia is headquartered in New York, New York, United States.
People Also Viewed
MishiPay
Developer of a mobile self-checkout technology designed to make online payments. The company's technology allows shoppers to pick up a product they wish to buy, scan the barcode and automatically pay with their phone, enabling shoppers to make secure cashless payments via a virtual mobile payment platform and save time by not waiting in queues.
DocLens.ai
Agentic AI Workflow for Complex Claims and Legal
Treiner
TREINER (treiner.com.au) is an Australian & New Zealand based holistic football coach booking marketplace offering a vast range of coaches in different fields & specialisations at locations, budget and experience to suit football players of all ages and abilities, whether you are a young player starting out, a youth player looking to move to the next level or a professional player looking for some specialist unbiased and objective training and feedback away from a club environment to help you gain your next contract.
PetaGene
Operator of a technology company intended to develop genomics data compression and acceleration software. The company's compression software addresses challenges caused by growing volumes of genomics data and transparently integrates it with existing storage infrastructure and bioinformatics pipelines, offering clients with a set of software tools that reduce the size and cost of NGS data for storage and transfer.
dotin
Developer of an artificial intelligence platform designed to capture digital personality fingerprint. The company's business to business, SaaS platform combines psychology, structured/unstructured social and/or enterprise data, and machine learning to identify subconscious motivators and leverage these vital personality insights to improve business outcomes and the workplace itself.
LiquidText
Developer of a computer-based active reading system software. The company offers a fluid document representation built on multi-touch input interaction techniques designed to facilitate the activities of active reading including manipulation of presentation of content, control what content is displayed and where, creation of annotations and other structures on top of content, as well as navigation through content.
Compare AccurKardia to the industry
AccurKardia operates across multiple industries. Browse revenue, funding, and growth data for AccurKardia in each sector below.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .